Publications

5808 Results

Association of diet quality with survival among people with metastatic colorectal cancer: data from CALGB/SWOG 80405 (Alliance)

Authors
E Van Blarigan;S Zhang;F-S Ou;A Venook;K Ng;C Atreya;K Van Loon;D Niedzwiecki;E Giovannucci;E Wolfe;H-J Lenz;F Innocenti;B O'Neil;J Shaw;B Polite;H Hochster;J Atkins;R Goldberg;R Mayer;CD Blanke;E O'Reilly;C Fuchs;J Meyerhardt
Journal / Conference
JAMA Network Open Oct 1;3(10):e2023500
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID33125497
PMC
PMC7599454
Study Number(s)
CTSU/C80405

Multiethnic Genomic and Transcriptomic Association Studies Identifies New Susceptibility Loci for Prostate Cancer

Authors
C Haiman;A Wang;PRACTICAL Consortium
Journal / Conference
American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #1324, poster
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Rare germline variants in ATM predispose to prostate cancer: A PRACTICAL Consortium study

Authors
Q Karlsson;Z Kote-Jarai;PRACTICAL Consortium
Journal / Conference
American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #2410, poster
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of androgen deprivation (AD) +/- cixutumumab in new metastatic hormone-sensitive prostate cancer (mHSPC)

Authors
R Wong;M Duong;C Tangen;N Agarwal;H Cheng;N Vogelzang;M Hussain;I Thompson;D Quinn;E Yu
Journal / Conference
J Clin Oncol 38, 2020 (suppl 6; abstr 106); ASCO GU Cancers Symposium 2020, poster
Year
2020
Research Committee(s)
Genitourinary
Study Number(s)
S0925

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Authors
D Rivera;TBD Other
Journal / Conference
Cancer Discovery Oct;10(10):1514-1527
Year
2020
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID32699031
PMC
PMC7541683

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Authors
N Kuderer;TBD Other
Journal / Conference
Lancet Jun 20;395(10241):1907-1918
Year
2020
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID32473681
PMC
PMC7255743

What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report

Authors
M Bertagnolli;C Blanke;W Curran;D Hawkins;R Mannel;P O'Dwyer;M Schnall;N Wolmark
Journal / Conference
Cancer Dec 1;126(23):5022-5029
Year
2020
Research Committee(s)
Multiple sites
PMID
PMID32970346
PMC
PMC7667615

Evaluating Serum Thymidine Kinase 1 (TK1) as a Prognostic and Predictive Marker in Estrogen Receptor (ER) Positive Metastatic Breast Cancer (MBC) Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial

Authors
C Paoletti;W Barlow;M Bergqvist;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, San Antonio TX), poster presentation, abst. PS2-04
Year
2020
Research Committee(s)
Breast
Study Number(s)
S0226

Dual Classification by Immune Response Signature and Homologous Recombination Deficiency Reveals Immune-Dependent and -Independent Prognostic Groups in patients with Triple Negative Breast Cancer (TNBC) treated with AC Chemotherapy (SWOG S9313)

Authors
S Stecklein;W Barlow;L Pusztai;TBA Myriad;TBA Almac;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation
Year
2020
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
K Kalinsky;W Barlow;F Meric-Bernstam;J Gralow;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;M Martin;M Gil Gil;C Arce-Salinas;E Brain;I Park;J-Y Pierga;A Lluch Hernandez;M Ramos Vazquez;M Ruiz Borrego;KH Jung;J-M Ferrero;A Schott;S Shak;P Sharma;DL Lew;J Miao;D Tripathy;G Hortobagyi;L Pusztai
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral presentation, abst. GS3-00
Year
2020
Research Committee(s)
Breast
Study Number(s)
S1007